ENTITY

Lifevantage (LFVN US)

11
Analysis
Consumer StaplesUnited States
Lifevantage Corporation is a health and nutrition company that develops dietary supplements. The Company produces nutritional products that are intended to combat oxidative stress to support brain, eye, and joint function, as well as skin canine products.
more
bullishLifevantage
05 Nov 2024 07:12Issuer-paid

LifeVantage Corporation - 1QFY25 EPS in Line on Better Margins

LFVN reported 1QFY25 ongoing EPS of $0.15 versus $0.13 in 1QFY24, up 15.4% and in line with our forecast. As has been the case recently, sales were...

Logo
52 Views
Share
bearishLifevantage
05 Sep 2024 18:35Issuer-paid

LifeVantage Corporation - Top-Line Headwinds Persist; Modestly Adjusting Estimates

4QFY24 sales were $48.9 million, down 9.8%, which was below our forecast of a 6.0% decline to $51.0 million. Local currency sales declined 8.0%,...

Logo
151 Views
Share
bullishLifevantage
22 Aug 2024 08:46Issuer-paid

LifeVantage Corporation - (LFVN) 4QFY24 Results Due Next Week

LFVN reports its 4QFY24 results on Wednesday, August 28, after market close. We are not changing our forecasts. Our detailed earnings models are...

Logo
150 Views
Share
bullishLifevantage
11 May 2024 06:42Issuer-paid

LifeVantage Corporation - 3QFY24 Profit Upside on Modest Sales Shortfall

EBITDA margin of 10.5% exceeded our 8.7% estimate, driven primarily by lower commissions and incentives as a percentage of sales than we expected...

Logo
366 Views
Share
bullishLifevantage
14 Feb 2024 08:43Issuer-paid

LifeVantage Corporation - Raising EPS & EBITDA Estimates; Trimming Sales

We are raising our EPS estimates for FY24 (June) to $0.60 from $0.55, FY25 (June) to $0.70 from $0.65, and FY26 (June) to $0.80 from $0.75. Since...

Logo
229 Views
Share
x